Covid-19 Impact on Artificial Vital Organs Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Artificial Vital Organs, including the following market information:
Major competitors identified in this market include Edwards Lifesciences Corporation, Abbott Diabetes Care, Baxter International, Ekso Bionics, Asahi Kasei Medical, Jarvik Heart, Ottobock Healthcare, etc.
Based on the Region:
- Global Artificial Vital Organs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Vital Organs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Vital Organs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Vital Organs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Edwards Lifesciences Corporation, Abbott Diabetes Care, Baxter International, Ekso Bionics, Asahi Kasei Medical, Jarvik Heart, Ottobock Healthcare, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Artificial Liver
- Artificial Heart
- Artificial Pancreas
- Artificial Kidney
- Artificial Lungs
- Others
- Hospitals
- Clinics
- Research Centers
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Artificial Vital Organs Industry
1.7 COVID-19 Impact: Artificial Vital Organs Market Trends
2 GLOBAL ARTIFICIAL VITAL ORGANS QUARTERLY MARKET SIZE ANALYSIS
2.1 Artificial Vital Organs Business Impact Assessment - COVID-19
2.1.1 Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Artificial Vital Organs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Artificial Vital Organs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Artificial Vital Organs Headquarters and Area Served
3.3 Date of Key Players Enter into Artificial Vital Organs Market
3.4 Key Players Artificial Vital Organs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ARTIFICIAL VITAL ORGANS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Artificial Liver
1.4.2 Artificial Heart
1.4.3 Artificial Pancreas
1.4.4 Artificial Kidney
1.4.5 Artificial Lungs
1.4.6 Others
4.2 By Type, Global Artificial Vital Organs Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ARTIFICIAL VITAL ORGANS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Research Centers
5.5.4 Others
5.2 By Application, Global Artificial Vital Organs Market Size, 2019-2021
5.2.1 By Application, Global Artificial Vital Organs Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Edwards Lifesciences Corporation
7.1.1 Edwards Lifesciences Corporation Business Overview
7.1.2 Edwards Lifesciences Corporation Artificial Vital Organs Quarterly Revenue, 2020
7.1.3 Edwards Lifesciences Corporation Artificial Vital Organs Product Introduction
7.1.4 Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
7.2 Abbott Diabetes Care
7.2.1 Abbott Diabetes Care Business Overview
7.2.2 Abbott Diabetes Care Artificial Vital Organs Quarterly Revenue, 2020
7.2.3 Abbott Diabetes Care Artificial Vital Organs Product Introduction
7.2.4 Abbott Diabetes Care Response to COVID-19 and Related Developments
7.3 Baxter International
7.3.1 Baxter International Business Overview
7.3.2 Baxter International Artificial Vital Organs Quarterly Revenue, 2020
7.3.3 Baxter International Artificial Vital Organs Product Introduction
7.3.4 Baxter International Response to COVID-19 and Related Developments
7.4 Ekso Bionics
7.4.1 Ekso Bionics Business Overview
7.4.2 Ekso Bionics Artificial Vital Organs Quarterly Revenue, 2020
7.4.3 Ekso Bionics Artificial Vital Organs Product Introduction
7.4.4 Ekso Bionics Response to COVID-19 and Related Developments
7.5 Asahi Kasei Medical
7.5.1 Asahi Kasei Medical Business Overview
7.5.2 Asahi Kasei Medical Artificial Vital Organs Quarterly Revenue, 2020
7.5.3 Asahi Kasei Medical Artificial Vital Organs Product Introduction
7.5.4 Asahi Kasei Medical Response to COVID-19 and Related Developments
7.6 Jarvik Heart
7.6.1 Jarvik Heart Business Overview
7.6.2 Jarvik Heart Artificial Vital Organs Quarterly Revenue, 2020
7.6.3 Jarvik Heart Artificial Vital Organs Product Introduction
7.6.4 Jarvik Heart Response to COVID-19 and Related Developments
7.7 Ottobock Healthcare
7.7.1 Ottobock Healthcare Business Overview
7.7.2 Ottobock Healthcare Artificial Vital Organs Quarterly Revenue, 2020
7.7.3 Ottobock Healthcare Artificial Vital Organs Product Introduction
7.7.4 Ottobock Healthcare Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Artificial Vital Organs Industry
1.7 COVID-19 Impact: Artificial Vital Organs Market Trends
2 GLOBAL ARTIFICIAL VITAL ORGANS QUARTERLY MARKET SIZE ANALYSIS
2.1 Artificial Vital Organs Business Impact Assessment - COVID-19
2.1.1 Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Artificial Vital Organs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Artificial Vital Organs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Artificial Vital Organs Headquarters and Area Served
3.3 Date of Key Players Enter into Artificial Vital Organs Market
3.4 Key Players Artificial Vital Organs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ARTIFICIAL VITAL ORGANS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Artificial Liver
1.4.2 Artificial Heart
1.4.3 Artificial Pancreas
1.4.4 Artificial Kidney
1.4.5 Artificial Lungs
1.4.6 Others
4.2 By Type, Global Artificial Vital Organs Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ARTIFICIAL VITAL ORGANS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Research Centers
5.5.4 Others
5.2 By Application, Global Artificial Vital Organs Market Size, 2019-2021
5.2.1 By Application, Global Artificial Vital Organs Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Edwards Lifesciences Corporation
7.1.1 Edwards Lifesciences Corporation Business Overview
7.1.2 Edwards Lifesciences Corporation Artificial Vital Organs Quarterly Revenue, 2020
7.1.3 Edwards Lifesciences Corporation Artificial Vital Organs Product Introduction
7.1.4 Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
7.2 Abbott Diabetes Care
7.2.1 Abbott Diabetes Care Business Overview
7.2.2 Abbott Diabetes Care Artificial Vital Organs Quarterly Revenue, 2020
7.2.3 Abbott Diabetes Care Artificial Vital Organs Product Introduction
7.2.4 Abbott Diabetes Care Response to COVID-19 and Related Developments
7.3 Baxter International
7.3.1 Baxter International Business Overview
7.3.2 Baxter International Artificial Vital Organs Quarterly Revenue, 2020
7.3.3 Baxter International Artificial Vital Organs Product Introduction
7.3.4 Baxter International Response to COVID-19 and Related Developments
7.4 Ekso Bionics
7.4.1 Ekso Bionics Business Overview
7.4.2 Ekso Bionics Artificial Vital Organs Quarterly Revenue, 2020
7.4.3 Ekso Bionics Artificial Vital Organs Product Introduction
7.4.4 Ekso Bionics Response to COVID-19 and Related Developments
7.5 Asahi Kasei Medical
7.5.1 Asahi Kasei Medical Business Overview
7.5.2 Asahi Kasei Medical Artificial Vital Organs Quarterly Revenue, 2020
7.5.3 Asahi Kasei Medical Artificial Vital Organs Product Introduction
7.5.4 Asahi Kasei Medical Response to COVID-19 and Related Developments
7.6 Jarvik Heart
7.6.1 Jarvik Heart Business Overview
7.6.2 Jarvik Heart Artificial Vital Organs Quarterly Revenue, 2020
7.6.3 Jarvik Heart Artificial Vital Organs Product Introduction
7.6.4 Jarvik Heart Response to COVID-19 and Related Developments
7.7 Ottobock Healthcare
7.7.1 Ottobock Healthcare Business Overview
7.7.2 Ottobock Healthcare Artificial Vital Organs Quarterly Revenue, 2020
7.7.3 Ottobock Healthcare Artificial Vital Organs Product Introduction
7.7.4 Ottobock Healthcare Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Artificial Vital Organs Assessment
Table 9. COVID-19 Impact: Artificial Vital Organs Market Trends
Table 10. COVID-19 Impact Global Artificial Vital Organs Market Size
Table 11. Global Artificial Vital Organs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Artificial Vital Organs Market Growth Drivers
Table 14. Global Artificial Vital Organs Market Restraints
Table 15. Global Artificial Vital Organs Market Opportunities
Table 16. Global Artificial Vital Organs Market Challenges
Table 17. By Players, Artificial Vital Organs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Artificial Vital Organs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Artificial Vital Organs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Artificial Vital Organs Market
Table 21. Key Players Artificial Vital Organs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Artificial Vital Organs Market Size 2019-2021, (US$ Million)
Table 24. Global Artificial Vital Organs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Artificial Vital Organs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 57. Edwards Lifesciences Corporation Business Overview
Table 58. Edwards Lifesciences Corporation Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Edwards Lifesciences Corporation Artificial Vital Organs Product
Table 60. Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
Table 61. Abbott Diabetes Care Business Overview
Table 62. Abbott Diabetes Care Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Diabetes Care Artificial Vital Organs Product
Table 64. Abbott Diabetes Care Response to COVID-19 and Related Developments
Table 65. Baxter International Business Overview
Table 66. Baxter International Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Baxter International Artificial Vital Organs Product
Table 68. Baxter International Response to COVID-19 and Related Developments
Table 69. Ekso Bionics Business Overview
Table 70. Ekso Bionics Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Ekso Bionics Artificial Vital Organs Product
Table 72. Ekso Bionics Response to COVID-19 and Related Developments
Table 73. Asahi Kasei Medical Business Overview
Table 74. Asahi Kasei Medical Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Asahi Kasei Medical Artificial Vital Organs Product
Table 76. Asahi Kasei Medical Response to COVID-19 and Related Developments
Table 77. Jarvik Heart Business Overview
Table 78. Jarvik Heart Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Jarvik Heart Artificial Vital Organs Product
Table 80. Jarvik Heart Response to COVID-19 and Related Developments
Table 81. Ottobock Healthcare Business Overview
Table 82. Ottobock Healthcare Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Ottobock Healthcare Artificial Vital Organs Product
Table 84. Ottobock Healthcare Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Artificial Vital Organs Assessment
Table 9. COVID-19 Impact: Artificial Vital Organs Market Trends
Table 10. COVID-19 Impact Global Artificial Vital Organs Market Size
Table 11. Global Artificial Vital Organs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Artificial Vital Organs Market Growth Drivers
Table 14. Global Artificial Vital Organs Market Restraints
Table 15. Global Artificial Vital Organs Market Opportunities
Table 16. Global Artificial Vital Organs Market Challenges
Table 17. By Players, Artificial Vital Organs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Artificial Vital Organs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Artificial Vital Organs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Artificial Vital Organs Market
Table 21. Key Players Artificial Vital Organs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Artificial Vital Organs Market Size 2019-2021, (US$ Million)
Table 24. Global Artificial Vital Organs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Artificial Vital Organs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Artificial Vital Organs Market Size, 2019-2021 (US$ Million)
Table 57. Edwards Lifesciences Corporation Business Overview
Table 58. Edwards Lifesciences Corporation Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Edwards Lifesciences Corporation Artificial Vital Organs Product
Table 60. Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
Table 61. Abbott Diabetes Care Business Overview
Table 62. Abbott Diabetes Care Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Diabetes Care Artificial Vital Organs Product
Table 64. Abbott Diabetes Care Response to COVID-19 and Related Developments
Table 65. Baxter International Business Overview
Table 66. Baxter International Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Baxter International Artificial Vital Organs Product
Table 68. Baxter International Response to COVID-19 and Related Developments
Table 69. Ekso Bionics Business Overview
Table 70. Ekso Bionics Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Ekso Bionics Artificial Vital Organs Product
Table 72. Ekso Bionics Response to COVID-19 and Related Developments
Table 73. Asahi Kasei Medical Business Overview
Table 74. Asahi Kasei Medical Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Asahi Kasei Medical Artificial Vital Organs Product
Table 76. Asahi Kasei Medical Response to COVID-19 and Related Developments
Table 77. Jarvik Heart Business Overview
Table 78. Jarvik Heart Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Jarvik Heart Artificial Vital Organs Product
Table 80. Jarvik Heart Response to COVID-19 and Related Developments
Table 81. Ottobock Healthcare Business Overview
Table 82. Ottobock Healthcare Artificial Vital Organs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Ottobock Healthcare Artificial Vital Organs Product
Table 84. Ottobock Healthcare Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Artificial Vital Organs Product Picture
Figure 2. Artificial Vital Organs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Artificial Vital Organs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Artificial Vital Organs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Artificial Vital Organs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Artificial Vital Organs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Artificial Vital Organs Market Size Market Share, 2019-2021
Figure 1. Artificial Vital Organs Product Picture
Figure 2. Artificial Vital Organs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Artificial Vital Organs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Artificial Vital Organs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Artificial Vital Organs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Artificial Vital Organs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Artificial Vital Organs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Artificial Vital Organs Market Size Market Share, 2019-2021
